DXCM catalyst calendar
Clinical trials led by listed companies, by the completion date the sponsor registered on ClinicalTrials.gov, soonest first, from today. Most future dates are the sponsor's estimate and can move.
- Completion LockedNo phase registeredNCT07212790REAL-Fam Feasibility Study for Youth Diabetes ManagementUniversity of North Carolina, Chapel Hill · Type 1 DiabetesActive, not recruitingDXCMCollaborator
- Enrollment
- Locked
- Primary completion
- Dec 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT06050265Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary SyndromeUniversity of California, San Francisco · PCOS (Polycystic Ovary Syndrome) of Bilateral OvariesActive, not recruitingDXCMCollaborator
- Enrollment
- Locked
- Primary completion
- Jul 12, 2025Actual
- Interventions
- Locked
- Completion LockedNo phase registeredNCT06601166CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on InsulinDexCom, Inc. · Type 2 DiabetesActive, not recruitingDXCMLead
- Enrollment
- Locked
- Primary completion
- May 13, 2026Actual
- Interventions
- Locked
- Completion LockedNo phase registeredNCT04783441Use of CGM in Kidney Transplant RecipientsUniversity of California, Davis · Kidney Transplant; ComplicationsRecruitingDXCMCollaborator
- Enrollment
- Locked
- Primary completion
- Dec 31, 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT06545227Early Versus Late Monitoring Among Pregnant Women With a History of Gestational DiabetesImperial College London · Pregnancy ComplicationsRecruitingDXCMCollaborator
- Enrollment
- Locked
- Primary completion
- May 1, 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedPhase 4NCT07603284Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi ArabiaDexCom, Inc. · Type 2 Diabetes on InsulinActive, not recruitingDXCMLead
- Enrollment
- Locked
- Primary completion
- Nov 2, 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT05360056Continuous Glucose Monitoring Following Hospital DischargeKathleen Dungan · Type 2 DiabetesActive, not recruitingDXCMCollaborator
- Enrollment
- Locked
- Primary completion
- Aug 31, 2024Actual
- Interventions
- Locked
- Completion LockedPhase 1NCT07681375Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 SensorDexCom, Inc. · Type 2 DiabetesActive, not recruitingDXCMLead
- Enrollment
- Locked
- Primary completion
- Jan 16, 2026Actual
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 8 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerHow to read this calendar
Completion dates as registered on ClinicalTrials.gov by the sponsor, for trials Signal8 links to a listed company. Most future dates are the sponsor's estimate and move. A completion date is when the last participant is measured, not when results are announced.
The window starts today. A date the sponsor registered to the day is listed when it falls inside the window; a date that has already passed is never listed as upcoming, even when the sponsor has not updated it yet. A date registered to the month only (shown as, say, Dec 2026) could be any day of that month, so it is listed only when the whole month falls inside the window. TrialScanner never adds a day the sponsor did not register.
By default the list shows trials where a listed company is the lead sponsor. Trials a listed company only collaborates on (as a partner, drug supplier or contract research organization) are added with the role filter, and every company is labelled Lead or Collaborator.
Free readers see the first 25 trials of any filter and windows up to 90 days, with the trial, phase, status, sponsor and primary completion. Enrollment, interventions, the start and completion dates, longer windows and later pages are part of the plan. See the methodology.